Intracellular production of Hepatitis C E2 polypeptides
US6521423B1 · kind B1 · utility
13Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2000 |
| Grant date | Feb 18, 2003 |
| Priority date | — |
| Expiry date | Oct 19, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/923
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for obtaining recombinantly produced, C-terminally truncated, E1 and E2 polypeptides from cell lysates are disclosed. The intracellularly expressed truncated molecules display improved biological properties as compared to their secreted counterparts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.